Discovery And Aerogen Collaborate

Discovery Laboratories, Inc. and Aerogen, Inc. have entered into a collaborative relationship to evaluate the use of Discovery’s proprietary humanized lung surfactant with Aerogen’s Aeroneb Professional Nebulizer System (Aeroneb Pro), for the delivery of aerosolized surfactants to prevent and treat respiratory disease in the hospital.

Aerogen’s commercially available Aeroneb Pro is a new nebulizer designed to provide efficient drug delivery for respiratory therapy, particularly for patients who require mechanical ventilation.

The Aeroneb Pro is designed to achieve a high level of efficiency by use of its proprietary technology, which produces a fine-particle, low speed aerosol, to maximize drug deposition in the lungs, without generating heat or requiring propellants or compressors.

The collaboration will investigate the application of the Aeroneb Pro with Discovery’s humanized lung surfactant for pulmonary delivery to the lungs of mechanically ventilated patients.

The initial investigations will include the selection of target formulation strengths and aerosol delivery parameters using an in vitro model of adult mechanical ventilation, in preparation for clinical evaluation.

“We are very excited to collaborate with Discovery Laboratories. Delivery of a humanized lung surfactant in aerosol form will be a significant step forward for respiratory medicine. The integration of their humanized surfactant with our Aeroneb Pro platform has the potential to achieve a marked improvement in respiratory drug therapy in the critical care setting,” said Jane E. Shaw, Ph.D., Chairman and CEO of Aerogen.

“The Aeroneb Pro technology offers a unique opportunity for use with mechanical ventilators common to the Intensive Care Unit.” Dr. Robert J. Capetola, Ph.D., President and CEO of Discovery stated.

Discovery Laboratories, Inc. is a specialty pharmaceutical company leveraging its platform technology in humanized lung surfactants to develop potential novel respiratory therapies and pulmonary drug delivery products.

is developing inhaler and nebulizer products, based on its proprietary aerosol generator technology, for the treatment of respiratory disorders in the home and hospital markets.


Online Dragon Pharma Anabolic Steroids – pharmaceutical company that manufactures steroid gear: Arimidex on Sale.

Acquire Dragon Pharma Labs of Top Quality

Trenbolone 100 - Cheap Price

Administration: Injection
Basic Substance: Trenbolone Acetate
Made by: Dragon Pharma
Package: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $52.00

Enantat 400

Injectable Anabolic Steroid
Basic Component: Testosterone Enanthate
Branded by: Dragon Pharma
Unit: 1 X 10 ml (400 mg/ml)

Winstrol Tabs - Cheap Price

Administration: Oral
Prime Substance: Stanozolol
Producer: Dragon Pharma LLC
Package: 20 x 100 tabs (50 mg/tab)
Price: 20 x $58.00

Winstrol Tabs - Bulk Price

Administration: Oral
Base Constituent: Stanozolol
Manufacturer: Dragon Pharmaceuticals
Package: 10 x 100 pastilles (50 mg/pastille)
Price: 10 x $63.00

Sustanon 350 - Cheap Price

Administration: Injection
Prime Component: Testosterone Blend
Made by: Dragon Pharmaceutical
Pack: 20 x 10 mL vial (350 mg/mL)
Price: 20 x $40.00


Selective Estrogen Receptor Modulator
Main Component: Clomiphene Citrate
Produced by: Dragon Pharmaceutical
Amount: 1 X 100 tabs (50 mg/pill)

Deca 300 [10 Vials]

Injectable Steroid for Muscle Growth
Prime Constituent: Nandrolone Decanoate
Made by: Dragon Pharma Labs
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $45.00 = $450.00 in Total

NPP 150

Injectable Steroid for Muscle Growth
Basic Component: Nandrolone Phenylpropionate
Producer: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (150 mg/mL)

Parabolan 100

Basal Substance: Trenbolone Hexahydrobenzylcarbonate
Producer: Dragon Pharmaceuticals
Amount: 10 mL vial (100 mg/mL)

Winstrol 50

Active Substance: Stanozolol
Branded by: Dragon Pharmaceuticals
Package: 10 mL vial (50 mg/mL)

Trenbolone 200

Principal Constituent: Trenbolone Enanthate
Made by: Dragon Pharma
Unit: 10 x 10 mL vial (200 mg/mL)

Deca 300

Main Substance: Nandrolone Decanoate
Produced by: Dragon Pharmaceutical
Unit: 10 mL vial (300 mg/mL)